Sessa Capital IM, L.P.
Q4 2021 13F-HR Holdings
Net value change ($000)
-12,142
(-0.6%)
New positions
8
Sold out positions
10
Turnover %
16.7%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| GTX | 139,044 | NEW |
| JXN | 82,104 | 70.2% |
| ONL | 79,722 | NEW |
| FLEX | 27,545 | NEW |
| CTVA | 18,779 | 12.4% |
| CC | 16,999 | 6.6% |
| IFF | 11,751 | 12.7% |
| 2seventy bio, Inc. | 8,766 | NEW |
| Gores Guggenheim, Inc. | 8,634 | 281.6% |
| Provention Bio, Inc. | 6,284 | 23.4% |
Top Reduces (Value $000, Stocks/ETFs)
| NXPI | -70,453 | -73.4% |
| bluebird bio, Inc. | -25,952 | -74.0% |
| PCG | -19,200 | -100.0% |
| ALLO | -14,286 | -74.1% |
| XERIS PHARMACEUTICALS INC | -8,970 | -100.0% |
| WFC | -7,974 | -5.2% |
| WW | -5,331 | -11.6% |
| T | -5,021 | -8.9% |
| DISH | -4,501 | -25.4% |
| Legacy EJY, Inc. | -2,814 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
175,708
(8.7% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|